Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Antiplatelet Agents: P2Y12 Inhibitors – Test Prep and Practice Pearls

Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Show Notes

P2Y12 inhibitors are a cornerstone of antiplatelet therapy in cardiovascular disease. These agents block the P2Y12 receptor on platelets, preventing ADP-mediated activation and reducing platelet aggregation. By inhibiting this amplification pathway, they help prevent arterial thrombosis in conditions such as acute coronary syndrome, percutaneous coronary intervention, stroke, and peripheral artery disease. The most commonly used oral agents include clopidogrel, prasugrel, and ticagrelor, each with important pharmacokinetic and clinical differences that influence agent selection.

From a pharmacist’s perspective, choosing the right P2Y12 inhibitor requires balancing ischemic benefit with bleeding risk. Clopidogrel requires CYP2C19 activation and is subject to drug interactions and genetic variability. Prasugrel provides more potent inhibition but carries a higher bleeding risk and is contraindicated in patients with prior stroke or TIA. Ticagrelor offers reversible inhibition but comes with unique considerations such as dyspnea and drug interactions via CYP3A4. Understanding these nuances allows pharmacists to optimize dual antiplatelet therapy and improve patient outcomes.

Be sure to check out our free Top 200 study guide – a 31 page PDF that is yours for FREE!

Support The Podcast and Check Out These Amazing Resources!

NAPLEX Study Materials

BCPS Study Materials

BCACP Study Materials

BCGP Study Materials

BCMTMS Study Materials

Nursing Pharmacology Review Course

Meded101 Guide to Nursing Pharmacology (Amazon Highly Rated)

Guide to Drug Food Interactions (Amazon Best Seller)

Pharmacy Technician Study Guide by Meded101

Pharmacy Technician Bootcamp (PTCB Exam Prep Course) – 4.8/5 star course rating

More from Real Life Pharmacology - Pharmacology Education for Health Care Professionals

Oct 22, 2026

Bisphosphonates are commonly used to prevent and treat osteoporosis, making them an important topic for pharmacy, nursing, and medical exams. In this episode of the Real Life Pharmacology Podcast, we review high-yield bisphosphonate facts and practical pearls to help you prepare for exams and improve medication management.

Oct 15, 2026

In this episode of Real Life Pharmacology, we take a closer look at several NSAIDs that are commonly encountered in clinical practice: nabumetone, diclofenac, meloxicam, piroxicam, etodolac, indomethacin, sulindac, and ketorolac.

Oct 8, 2026

Aspirin, ibuprofen, naproxen, and celecoxib are some of the most commonly used NSAIDs, but they are not interchangeable when it comes to safety, indications, and patient-specific risks. In this episode of Real Life Pharmacology, we compare these four medications and highlight the key differences pharmacists and other healthcare professionals need to know.

Oct 1, 2026

On this podcast episode, I cover the basics of NSAIDs, including how they work, what they are used for, significant drug interactions, and what adverse effects are important to monitor. I’ll educate about some of the major risks associated with NSAIDs and what I look out for as a practicing pharmacist.

Sep 24, 2026

In this episode of Real Life Pharmacology, we’re taking a closer look at three unique opioids: tramadol, tapentadol, and meperidine. These medications have some important differences in their mechanisms, clinical uses, drug interactions, and safety concerns. We’ll review the key pharmacology and practical clinical pearls you should know when using these opioids in real-world practice.

See all episodes →